Zoetis to Acquire Abaxis, a Leading Global Provider of Veterinary Point-of-Care Diagnostic Instruments
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Zoetis Inc. (ZTS) PT Raised to $82 at BMO Capital; Abaxis Deal Strong But Doesn't Change Thesis
May 17, 2018 1:06 PM EDTBMO Capital raised its price target on Zoetis Inc. (NYSE: ZTS) to $82.00 (from $80.00) while maintaining a Market Perform rating.
Analyst Alex Arfaei commented, "We have updated our model to include Abaxis acquisition. Overall, we see a strong strategic rationale for the... More
Abaxis (ABAX) to Resume Trading at 7:30 am ET
May 16, 2018 7:03 AM EDTAbaxis (NASDAQ: ABAX) to Resume Trading at 7:30 am ET
... More